News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Instil Bio Receives FDA Clearance to Begin Phase 1 Trial of AXN-2510 for Relapsed or Refractory Solid Tumours
Thursday, July 03, 2025Instil Bio Inc a clinicalstage biopharmaceutical company listed on NASDAQ TIL has announced that the US Food and Drug Administration FDA has cleared its Investigational New Drug IND application for AXN This is a PDLxVEGF bispecific antibody developed...
Vertex Receives European Commission Approval for ALYFTREK®, a New Once-Daily Treatment for Cystic Fibrosis
Wednesday, July 02, 2025Vertex Pharmaceuticals has announced that the European Commission has granted approval for ALYFTREK a oncedaily cystic fibrosis transmembrane conductance regulator CFTR modulator
Jazz Pharmaceuticals Gains Conditional EU Approval for Ziihera® to Treat Advanced HER2-Positive Biliary Tract Cancer
Wednesday, July 02, 2025Jazz Pharmaceuticals plc has received conditional marketing authorisation from the European Commission EC for Ziihera zanidatamab as a treatment for adults with unresectable locally advanced or metastatic HERpositive biliary tract cancer BTC who have...
Iksuda Therapeutics Secures FDA IND Clearance for IKS014 Targeting HER2-Positive Solid Tumours
Tuesday, July 01, 2025Iksuda Therapeutics has received clearance from the US Food and Drug Administration FDA for its Investigational New Drug IND application for IKS an antibodydrug conjugate ADC designed to target HERpositive
Takeda Gains U.S. FDA Approval for GAMMAGARD LIQUID ERC, a Ready-to-Use Low-IgA Immunoglobulin Therapy
Tuesday, July 01, 2025Takeda has received approval from the US Food and Drug Administration FDA for GAMMAGARD LIQUID ERC an immune globulin infusion human with low immunoglobulin A IgA content The approved formulation
